Sage Therapeutics Inc (SAGE) — Cash Flow Quality Index

Latest as of December 2020: 1.04x

Sage Therapeutics Inc (SAGE) has a Cash Flow Quality Index of 1.04x as of December 2020. Operating cash flow of $1.01 Billion exceeds net income of $974.89 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow conversion of Sage Therapeutics Inc to assess how effectively this company generates cash.

Cash Flow Quality Index

1.04x
Operating CF / Net Income

Operating Cash Flow

$1.01 Billion
USD

Net Income

$974.89 Million
USD

Data as of

Dec 2020
Most recent filing

Sage Therapeutics Inc Cash Flow Quality Index (2020–2020)

Historical Cash Flow Quality Index for Sage Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Sage Therapeutics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Sage Therapeutics Inc (2020–2020)

Year-by-year earnings quality comparison for Sage Therapeutics Inc. For live market cap and the full company financial profile, see Sage Therapeutics Inc stock valuation.

Year Quality Index Operating CF (USD) Net Income YoY Change
2020 1.10x $664.28 Million $606.07 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.